Page 823 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 34 Miscellaneous Tumors 801

120. U’Ren LW, Biller BJ, Elmslie RE, et al.: Evaluation of a novel 143. Carpenter JL, Valentine BA: Brief communications and case
tumor vaccine in dogs with hemangiosarcoma, J Vet Intern Med reports: squamous cell carcinoma arising in two feline thymomas,
21:113–120, 2007. Vet Pathol 29:541–543, 1992.
VetBooks.ir 121. Vail DM, MacEwen EG, Kurzman ID, et al.: Liposome-encap- 144. Vilafranca M, Font A: Thymolipoma in a cat, J Feline Med and Surg
7:125–127, 2005.
sulated muramyl tripeptide phosphatidylethanolamine adjuvant
immunotherapy for splenic hemangiosarcoma in the dog: a ran-
domized multi-institutional clinical trial, Clin Cancer Res 1:1165– 145. Robinson WC, Cantwell HD, Crawley RR, et al.: Invasive thy-
moma in a dog: a case report, J Am Anim Hosp Assoc 13:95–97,
1170, 1995. 1977.
122. Hillers KR, Lana SE, Fuller CR, et al.: Effects of palliative radiation 146. Bella JR, Stiff ME, Russel RG: Thymoma in the dog: two case
therapy on nonsplenic hemangiosarcoma in dogs, J Am Anim Hosp reports and review of 20 additional cases, J Am Vet Med Assoc
Assoc 43:187–192, 2007. 183:306–311, 1983.
123. Nolan MW, Arkans MM, LaVine, et al.: Pilot study to determine the 147. Day MJ: Review of thymic pathology in 30 cats and 36 dogs, J Sm
feasibility of radiation therapy for dogs with right atrial masses and Anim Pract 38:393–403, 1997.
hemorrhagic pericardial effusion, J Vet Cardiol 19:132–143, 2017. 148. Bell FW: Neoplastic diseases of the thorax, Vet Clin of North Am Sm
124. Lyles SE, Milner RJ, Kow K, et al.: In vitro effects of the tyrosine Anim Pract 17:387–409, 1987.
kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma 149. Darke PG: Myasthenia gravis, thymoma, and myositis in a dog, Vet
cell lines, Vet Comp Oncol 10:223–235, 2012. Rec 97:392–395, 1975.
125. London C, Mathie T, Stingle N, et al.: Preliminary evidence 150. Carpenter JL, Holzworth J: Thymoma in 11 cats, J Am Vet Med
for biologic activity of toceranib phosphate (Palladia(®)) in solid Assoc 181:248–251, 1982.
tumours, Vet Comp Oncol 10:194–205, 2012. 151. Turek MM: Cutaneous paraneoplastic syndromes in dogs and cats:
126. Gardner HL, London CA, Portela RA, et al.: Maintenance therapy a review of the literature, Vet Dermatol 14:279–296, 2003.
with toceranib following doxorubicin-based chemotherapy for 152. Rottenberg S, von Tscharner C, Roosje PJ: Thymoma-associated
canine splenic hemangiosarcoma, BMC Vet Res 11:131, 2015. exfoliative dermatitis in cats, Vet Pathol 41:429–433, 2004.
127. Borgatti A, Koopmeiners JS, Sarver AL, et al.: Safe and effective 153. Uchida K, Awamura Y, Nakamura T, et al.: Thymoma and mul-
sarcoma therapy through bispecific targeting of EGFR and uPAR, tiple thymic cysts in a dog with acquired myasthenia gravis, J Vet
Mol Cancer Ther 16:956–965, 2017. Med Sci 64:637–640, 2002.
128. Wirth KA, Kow K, Salute ME, et al.: In vitro effects of Yunnan 154. Stenner VJ, Parry BW, Holloway SA: Acquired myasthenia gravis
Baiyao on canine hemangiosarcoma cell lines, Vet Comp Oncol associated with a non-invasive thymic carcinoma in a dog, Aust Vet
14:281–294, 2016. J 81:543–546, 2003.
129. Egger C, Gibbs D, Wheeler J, et al.: Effect of oral administration of 155. Paciello O, Maiolino P, Navas L, et al.: Acquired canine myasthenia
Yunnan Baiyao on periprocedural hemorrhage in dogs undergoing gravis associated with thymoma: histological features and immuno-
nasal biopsy: a prospective, randomized, double-blinded controlled localization of HLA type II and IgG, Vet Res Commun 27(Suppl
study, Am Jour Trad Chin Vet Med 11:27–36, 2016. 1):715–718, 2003.
130. Frederick J, Boysen S, Wagg C, Chalhoub S: The effects of oral 156. Moffet AC: Metastatic thymomas and acquired generalized myas-
administration of Yunnan Baiyao on blood coagulation in beagle thenia gravis in a beagle, Can Vet J 48:91–93, 2007.
dogs as measured by kaolin-activated thromboelastography and 157. Singh A, Boston SE, Poma R: Thymoma-associated exfoliative der-
buccal mucosal bleeding times, Can J Vet Res 81:41–45, 2017. matitis with post-thymectomy myasthenia gravis in a cat, Can Vet J
131. Murphy LA, Panek CM, Bianco D, Nakamura RK: Use of yunnan 51:757–760, 2010.
baiyao and epsilon aminocaproic acid in dogs with right atrial masses 158. Foley P, Shaw D, Runyon C: Serum parathyroid hormone-related
and pericardial effusion, J Vet Emerg Crit Care 27:121–126, 2017. protein concentration in a dog with thymomas and persistent
132. Brown DC, Reetz J: Single agent polysaccharopeptide delays hypercalcemia, Can Vet J 41:867–870, 2000.
metastases and improves survival in naturally occurring hemangio- 159. Theilen GH, Madewell BR: Tumors of the respiratory tract and
sarcoma, Evid Based Comp Alt Med 2012, 2012. 3284301. thorax, ed 1, Veterinary cancer medicine, Philadelphia, 1979, Lea &
133. Alvarez FJ, Hosoya K, Lara-Garcia A, et al.: VAC protocol for treat- Febiger, pp 535–566.
ment of dogs with stage III hemangiosarcoma, J Am Anim Hosp 160. Harris CL, Klausner JS, Caywood DD, et al.: Hypercalcemia in a
Assoc 49:370–377, 2013. dog with thymomas, J Am Anim Hosp Assoc 27:281–284, 1991.
134. Gordon SS, McClaran JK, Bergman PJ, et al.: Outcome following 161. Bolliger AP, Graham PA, Richard V, et al.: Detection of parathy-
splenectomy in cats, J Fel Med Surg 12:256–261, 2010. roid hormone-related protein in cats with humoral hypercalcemia
135. Simonart T, Heenen M: Radiation-induced angiosarcomas, Der- of malignancy, Vet Clin Pathol 31:3–8, 2002.
matology 209:175–176, 2004. 162. Marconato L, Stefanello D, Valenti P, et al.: Predictors of long-
136. Parker GA, Casey HW: Thymomas in domestic animals, Vet Pathol term survival in dogs with high-grade multicentric lymphoma,
13:353–364, 1976. J Am Vet Med Assoc 238:480–485, 2011.
137. Aronsohn M: Canine thymomas, Vet Clin North Am 15:755–776, 163. Patterson MME, Marolf A: Sonographic characteristics of thy-
1985. moma compared with mediastinal lymphoma, J Am Anim Hosp
138. Robat CS, Cesario L, Gaeta R, et al.: Clinical features, treatment Assoc 50:409–413, 2014.
options, and outcome in dogs with thymoma: 116 cases (1990- 164. Reickle JK, Wisner ER: Non-cardiac thoracic ultrasound in 75
2010), J Am Vet Med Assoc 243:1448–1454, 2013. feline and canine patients, Vet Radiol and Ultrasound 41:154–162,
139. Zitz JC, Birchard SJ, Couto GC, et al.: Results of excision of thy- 2000.
momas in cats and dogs: 20 cases (1984-2005), J Am Vet Med Assoc 165. Larson MM: Ultrasound of the thorax (non-cardiac), Vet Clin of
232:1186–1192, 2008. North Am 39:733–745, 2009.
140. Aronsohn MG, Schunk KL, Carpenter JL, et al.: Clinical and 166. Gashen L, Kircher P, Hoffman G, et al.: Endoscopic ultrasound
pathologic features of thymomas in 15 dogs, J Am Vet Med Assoc for the diagnosis of intrathoracic lesions in two dogs, Vet Radiol
184:1355–1362, 1984. Ultrasound 44:292–299, 2003.
141. Atwater SW, Powers BE, Park RD, et al.: Canine thymomas: 23 167. Rae CA, Jacobs RM, Couto CG: A comparison between the cyto-
cases (1980-1991), J Am Vet Med Assoc 205:1007–1013, 1994. logical and histological characteristics in thirteen canine and feline
142. Patnaik AK, Lieberman PH, Erlandson RA, et al.: Feline cystic thymomas, Can Vet J 30:497–500, 1989.
thymomas: a clinicopathologic, immunohistologic, and electron 168. Cowell RL, Tyler RD, Meinkoth JH: The lung parenchyma. In
microscopic study of 14 cases, J Feline Med Surg 5:27–35, 2003. Diagnostic cytology of the dog and cat, ed 2, St Louis, 1999, Mosby.